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Abstract
In recent years it has become clear that the therapeutic properties of bone marrow-derived mesenchymal stromal cells
(MSC) are related not only to their ability to differentiate into different lineages but also to their capacity to suppress the
immune response. We here studied the influence of MSC on macrophage function. Using mouse thioglycolate-elicited
peritoneal macrophages (M) stimulated with LPS, we found that MSC markedly suppressed the production of the
inflammatory cytokines TNF-a, IL-6, IL-12p70 and interferon-c while increased the production of IL-10 and IL-12p40. Similar
results were observed using supernatants from MSC suggesting that factor(s) constitutively released by MSC are involved.
Supporting a role for PGE2 we observed that acetylsalicylic acid impaired the ability of MSC to inhibit the production of
inflammatory cytokines and to stimulate the production of IL-10 by LPS-stimulated M. Moreover, we found that MSC
constitutively produce PGE2 at levels able to inhibit the production of TNF-a and IL-6 by activated M. MSC also inhibited the
up-regulation of CD86 and MHC class II in LPS-stimulated M impairing their ability to activate antigen-specific T CD4+ cells.
On the other hand, they stimulated the uptake of apoptotic thymocytes by M. Of note, MSC turned M into cells highly
susceptible to infection with the parasite Trypanosoma cruzi increasing more than 5-fold the rate of M infection. Using a
model of inflammation triggered by s.c. implantation of glass cylinders, we found that MSC stimulated the recruitment of
macrophages which showed a low expression of CD86 and the MHC class II molecule Ia
b and a high ability to produce IL-10
and IL-12p40, but not IL-12 p70. In summary, our results suggest that MSC switch M into a regulatory profile characterized
by a low ability to produce inflammatory cytokines, a high ability to phagocyte apoptotic cells, and a marked increase in
their susceptibility to infection by intracellular pathogens.
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Introduction
Bone marrow-derived mesenchymal stromal cells (MSC) are
pluripotent adult stromal cells able to differentiate into different cell
types such as osteoblasts, chondrocytes and adipocytes [1]. These
cells preferentially home to damaged tissues and therefore they have
attracted scientific attention as potential therapeutic tools for tissue
repair [1–3]. Studies performed in the last years, however,
demonstrated that MSC exert potent immunomodulatory effects
and support the notion that the therapeutic potential of MSC is not
only related to their ability to differentiate into different lineages but
also to their capacity to suppress the immune response [4,5].
A larger number of studies mainly performed in vitro have
shown that MSC display immunomodulatory capacities. MSC
inhibit the differentiation of monocytes and CD34+ haematopoi-
etic progenitor cells into dendritic cells (DC) [6,7]. They suppress
the maturation of DC and the ability of DC to produce
inflammatory cytokines as well as T helper-type 1 (Th1)-
promoting cytokines such as IL-12p70 [6–9]. MSC inhibit
cytotoxicity and production of interferon-c by NK cells [10,11],
and also exert a potent immunosuppressive effect on T cells. They
suppress T-cell proliferation induced by alloantigens, mitogens
and soluble antigens [12–14]. Interestingly, this inhibition appears
to be not MHC restricted as it can be induced by either autologous
or allogeneic MSC. Other immunosuppressive effects mediated by
MSC on T cells include down regulation of T-CD8+-mediated
cytotoxicity [15] and expansion of regulatory T cells [16]. MSC
are also able to regulate B cell function, suppressing both,
proliferation of B cells in response to anti-Ig antibodies, soluble
CD40, and cytokines, and antibody production [17,18]. The
mechanisms underlying the immunosuppressive effects mediated
by MSC are not fully defined, but they appear to be largely
mediated by a number of soluble factors produced by MSC, either
constitutively or in response to paracrine signals derived from
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factor-b1 (TGFb1), hepatocyte growth factor, PGE2, indoleamine
2,3-dioxygenase (IDO), haem oxygenase-1, soluble HLA-G5, IL-
10 and IL-6 [4,5,14].
Little is known about the effect of MSC on macrophages, a
critical player of the innate immune response involved in almost all
immune-mediated diseases. In the present study we analyzed this
subject. We show here that MSC turns activated macrophages into
a regulatory profile characterized by a low ability to produce
inflammatory cytokines, a high ability to phagocyte apoptotic cells,
and a dramatic increase in their susceptibility to infection with the
parasite Trypanosoma cruzi (T. cruzi).
Materials and Methods
Mice
All experiments were conducted using 2-mo-old virgin female
C57BL/6 mice or ovalbumin (OVA)-specific, MHC II-restricted,
T-cell-receptor transgenic mice (OT-II mice). OT-II mice carry a
transgenic CD4 TCR specific for the MHC class II-restricted
OVA peptide aa 323–339. Mice were housed six per cage and kept
at 2062uC under automatic 12-h light-dark schedule. All animal
experiments were performed according to the NIH Guide for the
Care and Use of Laboratory Animals and approved by the ethical
committee of the ‘‘Instituto de Leucemia Experimental’’ (ILEX)
(Academia Nacional de Medicina, Buenos Aires, Argentina).
Mouse MSC cultures
MSC were isolated and cultured using standard protocols [19].
Bone marrow cells from C57BL/6 mice were collected by flushing
the femurs and tibias from 8–12-week-old mice with RPMI medium
supplemented with 5% heat-inactivated fetal calf serum (FCS)
(Invitrogen, CA, USA). Erythrocytes-depleted bone marrow cells
were plated at a density of 4610
6 cells per cm
2 in RPMI medium
supplemented with 10% FCS, 100 IU/ml penicillin and 100 mg/ml
streptomycin (Invitrogen). Culture medium was changed at day 2 to
remove nonadherent cells. Whole medium was subsequently
replaced weekly. The cells were grown for 3–4 weeks until almost
confluent. Adherent cells were then detached by 0.25% trypsin-
EDTA and replated using a 1:3 dilution until passage 2. Subsequent
passaging and seeding of the cells were performed at a density of
5,000 cells per cm
2. MSC were used after 4–7 passages.
Analysis of MSC
Osteogenic and adipogenic differentiation assays were per-
formed as previously described [20]. For standard osteogenic
differentiation, confluent monolayers of MSC were incubated in
medium supplemented with 10
28 M dexamethasone, 50 mM
ascorbic acid, and 10 mM b-glycerol phosphate (Sigma-Aldrich,
Buenos Aires, Argentina) with changes of medium every 5 days.
After 30 days the cultures were fixed with 70% cold ethanol for 1 h
at room temperature, and incubated with Alizarin Red S (2%
aqueous solution, pH 4.1–4.3, adjusted with ammonium hydrox-
ide) for 30 min. Excess stain was removed by washing four times
with water. For standard adipogenic differentiation, confluent
monolayers of MSC were incubated in medium supplemented
with 10
28 M dexamethasone and 10
24 M L-ascorbic acid 2-
phosphate (Sigma-Aldrich) with changes of medium every 5 days.
After 30 days, the cultures were fixed in 3% formaldehyde in PBS
for 10 minutes and stained with Oil Red O.
The phenotype of MSC was analyzed by flow cytometry using a
FACScan flowcytometer (BD Biosciences, NJ, USA). The
following mAb were used: fluorescein isothiocyanate (FITC)-
labeled anti-CD3, anti-B220, anti-CD31, anti-TER119, anti-
SCA-1, anti-CD90, phycoerythrin (PE)-labeled anti-CD11b,
anti-GR1, anti-CD45, anti-CD11c, anti-Ly6C, and anti-CKIT
(BD Biosciences). Isotype controls were used in all cases. To block
unspecific antibody binding cells were pre-treated for 30 min at
4uC with saturating concentrations of anti-mouse Fcc receptor
blocking antibodies purified from 24G2 hybridoma supernatants.
Inflammatory peritoneal macrophages
Thioglycolate-elicited peritoneal macrophages (M) were obtained
as previously described [21]. Briefly, 30 g of dehydrated Brewer
thioglycolate medium powder (Sigma-Aldrich) was dissolved in
1000 mL deionized water and autoclaved for 20 minutes at 15
pounds of pressure (121uC). The preparation was kept in the dark
under sterile conditions at room temperature for at least 6 months
before use. Peritoneal exudate cells were elicited by i.p. injection of
2 ml of 3% sterile thioglycolate. Cells, consisting mostly of
macrophages (over 90%), were harvested by peritoneal lavage using
5 ml RPMI medium supplemented with 5% FBS, 4 days after
intraperitoneal injection of thioglycolate. Cells were plated in 48-well
flat-bottom culture plates at 5610
5 cells/well in RPMI medium
supplemented with 10% fetal bovine serum, 100 IU/ml penicillin
and 100 mg/ml streptomycin. After 2 h of incubation at 37uC
nonadherent cells were removed by vigorous washing. The purity of
macrophage preparations (over 98%) was assessed by flow
cytometry using FITC-labeled IgG anti-CD11b (BD Biosciences).
The phenotype of macrophages was analyzed using FITC- or PE-
labeled mAb directed to CD86, Ia
b, CD40, H2D
b, CD36, CD14,
and Toll-like receptor 2 (TLR2) (BD Biosciences). Isotype controls
were used in all cases. To block unspecific antibody binding, cells
were pre-treated for 30 min at 4uC with saturating concentrations of
anti-mouse Fcc receptor blocking antibodies purified from 2.4G2
hybridoma supernatants. When indicated, macrophages were
treated with a blocking antibody directed to the IL-10 receptor
(10 mg/ml, 1B1.3a, BD Biosciences).
Co-culture of macrophages and mesenchymal stromal
cells
MSC and M were suspended in RPMI medium supplemented
with 10% heat-inactivated FCS, 100 IU/ml penicillin and 100 mg/
ml streptomycin. MSC were plated in 48-well flat-bottom plates at
5610
3 cells/cm
2. Once cells reached confluence, 5610
5 macro-
phages were added to each well (MSC: M ratio ,1:10). Controls
include M and MSC cultured alone. Cells were cultured overnight
and then incubated for an additional period of 18 h with or without
LPS 30 ng/ml. For generation of MSC-conditioned medium, MSC
grown to confluence were incubated for 24 h at 37uC. Supernatants
were then collected and stored at 220uCu n t i lu s e .
Analysis of cytokine production by ELISA
M, MSC, and M plus MSC cultured overnight were incubated
for an additional period of 18 h with or without LPS, and the
presence of the follow cytokines in the supernatants was evaluated
by ELISA: TNF-a, IL-6, IL-12p70, IL-23, IL-12p40, IFN-c (e-
Bioscience,CA, USA), and IL-10 (BD Biosciences), following
manufacturer’s instructions. Production of prostaglandin E2
(PGE2) in the supernatants of MSC was evaluated by ELISA
(Cayman Chemical). When indicated, cells were incubated in the
presence of acetylsalicylic acid (ASA) or PGE2 (Sigma-Aldrich).
Analysis of cytokine production by intracellular staining
and flow cytometry
To establish the cellular source of the cytokines released in the
co-cultures of M and MSC, the production of TNF-a and IL-10
Macrophages and MSC
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these experiments, M, MSC, and M plus MSC cultured overnight,
were incubated for 18 h with or without LPS. Brefeldin A (10 mg/
ml) was added during the last 6 h of culture to inhibit the release of
cytokines. Cells were detached with cold-PBS, resuspended in
RPMI medium supplemented with 5% FCS, and incubated with
saturating concentrations of anti-mouse Fcc receptor blocking
antibodies purified from 2.4G2 hybridome supernatants. Cells
were then stained with FITC-labeled antibodies directed to
CD11b, washed, fixed, permeabilized and stained with PE-labeled
antibodies directed to TNF-a or IL-10 (BD Biosciences).
Proliferation of OT-II TCD4+ cells induced by OVA-primed
macrophages
Thioglycolate-elicited peritoneal macrophages (M) (1610
5 cells/
100 ml) were cultured overnight in 96 well-flat bottom plates with
culture medium alone or MSC-conditioned medium. After
washing, cells were treated with LPS (30 ng/ml) in the absence
or presence of OVA (500 mg/ml) for 18 hs. After this period, M
were washed and fresh culture medium was added. Spleen T
CD4+ cells from OT-II mice were purified by negative selection
using a T CD4+ cell isolation kit (Miltenyi). Purified T CD4+ cells
(.95% purity) were labeled with carboxyfluorescein diacetate
succinimidyl ester (CFSE, Molecular Probes) (5 mM, 15 min at
37uC). Cells were washed and analyzed by flow cytometry to be
sure that all the cells showed a single fluorescence peak.
Macrophages and CFSE-labeled OT-II T CD4+ cells were
cultured together (M:T cell ratio 1:5) for 72 h. Cells were then
harvested and stained with PE-labeled anti-CD4 mAb (BD
Pharmingen). Proliferation of the CFSE-labeled T CD4+ cells
was analyzed by flow cytometry.
Quantification of cellular apoptosis and viability by
fluorescence microscopy
Quantification was performed by fluorescence microscopy, as
previously described [22], using the fluorescent DNA-binding dyes
acridine orange (Sigma-Aldrich) (100 mg/ml, to determine the
percentage of cells that had undergone apoptosis) and ethidium
bromide (Sigma-Aldrich) (100 mg/ml; to differentiate between
viable and non-viable cells). With this method, non-apoptotic cell
nuclei show ‘structure’, i.e. variations in fluorescence intensity that
reflect the distribution of euchromatin and heterochromatin. By
contrast, apoptotic nuclei exhibit highly condensed chromatin that
is uniformly stained by acridine orange. In fact, the entire
apoptotic nucleus are present as bright spherical beads. To assess
the percentage of cells showing morphological features of
apoptosis, at least 200 cells were scored in each experiment.
Phagocytosis of apoptotic thymocytes by macrophages
Thymuses were obtained from 6–8-week-old C57BL/6 mice
and minced to yield a single-cell suspension. Thymocytes were
labeled with carboxyfluorescein diacetate succinimidyl ester
(CFSE) (5 mM, 15 min at 37uC). To induce apoptosis, thymocytes
were cultured in RPMI medium supplemented with 5% FCS and
2 mM dexamethasone at a concentration of 5610
6 cells/ml for
8 h. This treatment yields a population with more than 80% of
apoptotic thymocytes and a low degree of contamination by late
apoptotic or necrotic cells. M were plated in 48-well flat-bottom
culture plates at a concentration of 5610
5 macrophages per well,
and incubated overnight in RPMI medium supplemented with
10% heat-inactivated FCS, 100 IU/ml penicillin and 100 mg/ml
streptomycin, in the absence or presence of MSC (M: MSC ratio
10:1). Apoptotic tymocytes were then added (M: thymocyte
ratio=1:10), and cells were incubated for 1 h at 37uC. Cultures
were then washed extensively with RPMI and detached with cold
PBS. The number of apoptotic thymocytes inside each macro-
phage was determined by fluorescence microscope using PE-
labeled IgG anti-CD11b. At least 200 macrophages were scored in
each experiment.
Phagocytosis of zymosan particles by macrophages
M were plated in 48-well flat-bottom culture plates at a
concentration of 5610
5 macrophages per well, and incubated
overnight in RPMI medium supplemented with 10% heat-
inactivated FCS, 100 IU/ml penicillin and 100 mg/ml streptomy-
cin, in the absence or presence of MSC (M: MSC ratio 10:1).
FITC-zymosan (250 mg/ml) was added and phagocytosis of
zymosan particles by M was analyzed after 1 h of incubation at
37uC, using PE-labeled IgG anti-CD11b and flow cytometry.
Infection of macrophages by Trypanosoma cruzi
Macrophages (2.5610
5/well), were cultured overnight in the
absence or presence of MSC (M: MSC ratio=10:1) in 8-
chamber-slides (Nunc TM, PA, USA). Then, cells were infected
with bloodstream trypomastigotes of the T. cruzi strain RA [23] at
M: T. cruzi ratio of 1:5 for 3 h at 37uC. The cultures were washed
five times to remove free parasites and the cells were cultured for
an additional period of 45 h at 37uC under 5% CO2. Cells were
then washed, fixed (4% paraformaldehyde in PBS for 20 min at
room temperature) and permeabilized (0.1% Triton X-100 in
PBS). Fcc receptors were blocked using saturating concentrations
of anti-mouse Fcc receptor blocking antibodies purified from
2.4G2 hybridoma supernatants, and the infection of M was
determined by analyzing the presence of intracellular amastigotes
by immunofluorescence assays using a rabbit polyclonal serum
directed to T. cruzi and FITC-labeled goat anti-rabbit IgG
(Sigma-Aldrich) and PE-labeled antibodies directed to CD11b.
Cells were mounted onto microscopic slides using 10% glycerol
containing the anti-fade reagent paraphenylenediamine. At least
twenty random microscopic fields (400X) and 1000 cells per
culture were acquired using a Spot RT digital camera attached to
a Nikon Eclipse 600 fluorescence microscope (Nikon Inc),
supplied with the adequate excitation and emission filters. Cell
quantification was performed with the ImageJ open source
software developed at the National Institutes of Health (NIH,
USA).
Mice infection by T. cruzi
Two-months old C57Bl/6 female mice were infected by
intraperitoneal (IP) route with 1610
5 bloodstream trypomastigotes
of the lethal pantropic/reticulotropic RA strain of Trypanosoma
cruzi, as previously described [24]. This parasite strain is routinely
maintained by weekly passages in CF1 mice. MSC (2.5610
6/
500 ml pyrogen-free PBS) or PBS (controls) were inoculated by
intraperitoneal route at days 4 and 10 post-infection. Parasitemia
was measured after the tenth day post-infection. Blood was
obtained from a small cut at the end of the tail. The blood was
diluted fivefold in red blood cell lysis buffer (150 mM NH4Cl,
0.1 mM EDTA, and 10 mM KHCO3, pH 7.4), and parasitemia
was measured in a Neubauer chamber. Mouse deaths were
recorded on a daily basis.
Inflammatory response induced by s.c. implantation of
glass cylinders
A model of chronic inflammation was carried out in C57BL/6
mice, as previously described [25]. Briefly, glass cylinders of 2 cm
Macrophages and MSC
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implanted s.c. into 8-to 12-week-old C57BL/6. It has been shown
that the cylinders cause a strong inflammatory process that leads to
their infiltration predominantly by macrophages and also to the
close of both ends of the cylinders by fibrotic tissue [25]. Two and
7 days after the cylinders were implanted in the mice, 2610
5 MSC
in 50 ml of pyrogen free-PBS or 50 ml pyrogen-free PBS alone
(controls) were inoculated inside the cylinders, using a 22 g needle.
After 15 days the liquid content of the cylinders was aspirated
using a 22 g needle, centrifuged and the levels of the cytokines
TNF-a, IL-12p70, IL-12p40 and IL-10 were determined by
ELISA. Cylinders were removed, washed with saline and placed in
cold PBS (4uC) for 30 min. Using a specially designed scraper,
adherent cells were then removed from the interior of each
cylinder (.90% macrophages) to obtain a single cell suspension.
The phenotype of adherent macrophages was analyzed by flow
cytometry.
Statistical analysis
Student’s paired t test was used to determine the significance of
differences between mean values, and p,0.05 was determined to
indicate statistical significance. Differences in the survival of mice
infected by T. cruzi were analysed by means of the Kaplan-Meier
test followed by log-rank (Mantel-Haenszel) test.
Results
MSC characterization
Mouse MSC were obtained from bone marrow of adult
C57BL/6J mice by adherence to plastic culture flasks as previously
described [19]. Cells had been passaged from 4 to 7 times were
used in all the experiments. Flow cytometric analysis demonstrated
that MSC were devoid of typical hematopoietic and endothelial
markers. MSC did not express CD11b, CD45, CD31, CD34,
CD11c, Gr-1, c-kit, TER-119, B220, CD3, but express MSC-
associated antigens such as Sca-1 (stem cell antigen-1) and CD90.2
(Figure 1A). Morphologically, these cells had a spindled,
fibroblast appearance after expansion (Figure 1B). Culture in
adipocyte-differentiation media induced the differentiation of
MSC into cells containing drops of fat revealed by the colorant
Oil Red O, while the culture of MSC in osteogenic-differentiation
media results in the formation of calcium containing precipitates
which were visualized by staining with Alizarin Red S
(Figures 1C and D).
MSC turns inflammatory macrophages into a regulatory
profile
In a first set of experiments we examined the ability of MSC to
modulate the production of cytokines by thioglycolate-elicited
Figure 1. Characterization of bone marrow-derived mesenchymal stromal cells (MSC). MSC were isolated from bone marrow of adult
C57BL/6J and cultured using standard protocols. (A) Analysis of the phenotype of MSC by flow cytometry. Grey histograms represent isotype controls
(B) Morphology of MSC. (C) Culture of MSC in adipocyte-differentiation media showing cells containing drops of fat revealed by Oil Red O. (D) Culture
of MSC in osteogenic-differentiation media showing the formation of calcium containing precipitates stained by Alizarin Red S. A representative
experiment is shown.
doi:10.1371/journal.pone.0009252.g001
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Materials and Methods, and they were cultured overnight in the
absence or presence of MSC (M: MSC ratio=10:1). Cells were
then washed and incubated for an additional period of 18 h with
or without LPS (30 ng/ml), and the presence of the cytokines
TNF-a, IL-6, IL-12p70, IL-23, IL-12p40 and IL-10 was evaluated
in the supernatants by ELISA. The results obtained are shown in
Figure 2A. Little or no production of cytokines was observed in
the cultures of M, MSC or M plus MSC performed in the absence
of LPS. Addition of LPS did not stimulate the production of
cytokines by MSC but triggered a burst of cytokine production by
M. Interestingly, MSC markedly suppressed the production of the
proinflammatory cytokines TNF-a, IL-6, and IL-12p70 while
increased the production of both IL-12p40 and the anti-
inflammatory cytokine IL-10. No production of IL-23 was
detected in any condition.
To evaluate the possible contribution of MSC to the production
of cytokines observed in co-cultures of M and MSC stimulated by
LPS, the presence of TNF-a and IL-10 was analyzed by
intracellular staining and flow cytometry. Activation by LPS
resulted in the stimulation of TNF-a and IL-10 production by M
but not by MSC and, consistent with the analysis of cytokines
performed by ELISA in culture supernatants, intracellular staining
of M showed that MSC inhibit the production of TNF-a while
increased the production of IL-10 (Figure 2B).
Interferon-c (IFN-c) plays a critical role in innate and adaptive
immunity. It is the key cytokine to induce the activation of
macrophages by increasing the expression of MHC class II and
costimulatory molecules and the production of inflammatory
mediators enabling macrophages to display a high anti-microbial
and tumoricidal activity [26,27]. IFN-c is typically produced by
NK cells, NKT cells, TH1 cells and T CD8+ cells [26,27]. A
number of studies have proposed that macrophages are also able
to produce IFN-c [28-31]. Our results showed in Figure 2C
indicated that M produced substantial amounts of IFN-c upon
activation by LPS, and also that the production of IFN-c was
markedly diminished by MSC. While this result reinforces the
notion that MSC suppress the production of inflammatory
cytokines, the cellular source of IFN-c in the cultures of M
remains uncertain. It should be noted that our preparations of
macrophages collected from peritoneal exudates contained
between 1.0 and 2.0% of contaminant lymphocytes, and previous
studies challenging the assumption that myeloid cells produce
IFN-c demonstrated that the production of IFN-c by inflamma-
tory peritoneal macrophages could be accounted by the presence
of minute numbers of contaminating lymphocytes (,0.4%), some
of which express myeloid markers and hence, are not easily
distinguishable from macrophages [32,33].
Experiments were then designed to determine whether the
modulation exerted by MSC on the production of cytokines by M
was dependent on cell-to-cell contact and/or was mediated by
soluble factors released by MSC. To this aim, MSC grown to
confluence were cultured alone for 24 h and the supernatants were
collected. Figure 3 shows that supernatants from MSC (50% v/v)
exerted a modulatory action similar than MSC. In fact, MSC
supernatants inhibited the production of the pro-inflammatory
Figure 2. MSC inhibit the production of inflammatory cytokines and enhance the production of IL-10 by thioglycolate-elicited
peritoneal macrophages (M). M were cultured overnight in the absence or presence of MSC (M: MSC ratio=10:1). Cells were then washed and
incubated for 18 h with or without LPS (30 ng/ml), and cytokines were analyzed in cell-supernatants by ELISA (A and C) or by intracellular staining
and flow cytometry (B). (A and C) Results are expressed in pg/ml and represent the arithmetic mean 6 SEM of 5–6 experiments. (B) Representative
dot-plots (n=4) are shown. Inside the circle MSC. *, p,0.05 for M+MSC+LPS vs M+LPS.
doi:10.1371/journal.pone.0009252.g002
Macrophages and MSC
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production of IL-12p40 and IL-10 by LPS-activated M. The
ability of MSC supernatants to inhibit the production of TNF-a
and to stimulate the production of IL-10, however, was lower in
comparison with the effect mediated by MSC (see Figure 2A)
perhaps reflecting the short half life of the mediator(s) released by
MSC and/or the participation of cell-to-cell contact-dependent
mechanisms.
Data in Figure 4 showed that the ability of MSC to down-
regulate the production of inflammatory cytokines and up-regulate
the production of IL-10 by LPS-stimulated M was strongly
inhibited when co-cultures of M and MSC were performed in the
presence of acetylsalicylic acid (ASA), a cyclo-oxygenase inhibitor.
This suggests that MSC regulate the cytokine profile of activated
M through the release of PGE2, one of the major immunomod-
ulator factors produced by MSC [4,5,14]. We then analyzed
whether MSC constitutively produce PGE2. MSC were grown to
confluence and cultured for an additional period of 24 h.
Supernatants were collected and the levels of PGE2 were
determined by ELISA. MSC supernatants contained 4.361.2
ng/ml of PGE2 (mean 6 SEM, n=4). Interestingly, data showed
in Figure 4B indicated that these concentrations of PGE2 were
able to significantly inhibit the production of TNF-a and IL-6 by
LPS-stimulated M. On the other hand, since data in Figure 2A
showed that MSC constitutively produce low levels of IL-10 we
performed another set of experiments using blocking antibodies
directed to the IL-10 receptor to determine whether IL-10
secreted by MSC could contribute to the inhibition of the
production of inflammatory cytokines by LPS-stimulated M. We
observed that treatment of macrophages with anti-IL-10 receptor
antibodies (10 mg/ml) did not impair the ability of MSC
supernatants to inhibit the production of IL-6 and IL-12p70 by
activated macrophages (data not shown).
Not only the production of cytokines but also the phenotype of
activated M was regulated by MSC. Results shown in Figure 5A
indicated that MSC significantly impaired the up-regulation in the
expression of both, the costimulatory molecule CD86 and MHC
class II (Ia
b) induced by LPS, without affecting the expression of
CD40 and the class I molecule H2D
b. Similar results were
observed with supernatants collected from MSC cultures (data not
shown). The ability of MSC to prevent the up-regulation of CD86
and Ia
b in LPS-stimulated M supports the notion that MSC might
impair the ability of M to act as an antigen-presenting cell. This
hypothesis was analyzed using T CD4+ cells isolated from the
spleen of OT-II mice, which bear a transgenic ab T cell receptor
specific for the MHC class II-restricted OVA 323–339 peptide. In
these experiments, M were cultured overnight in 96 well-flat
Figure 3. MSC regulate the profile of cytokines produced by
activated M through the release of soluble factor(s). MSC grown
to confluence were cultured alone for 24 h and the cell-supernatants
were then harvested. M were cultured for 18 h with or without LPS
(30 ng/ml) in the absence or presence of MSC supernatants (50% V/V)
and cytokines were analyzed in cell-supernatants by ELISA. Results are
expressed in pg/ml and represent the arithmetic mean 6 SEM of 5
experiments. *, p,0.05 for M+Sn+LPS vs M+LPS.
doi:10.1371/journal.pone.0009252.g003
Figure 4. Acetylsalicylic acid (ASA) impairs the ability of MSC
to modulate the profile of cytokines produced by M. (A) M were
cultured overnight in the absence or presence of MSC (M: MSC
ratio=10:1) with or without ASA (0.5 mM). Cells were then washed and
incubated for 18 h with LPS (30 ng/ml), in the absence or presence of
ASA (0.5 mM) and cytokines were analyzed in cell-supernatants by
ELISA. (B) M were cultured overnight in the absence (controls) or
presence of different concentrations of PGE2. Then, cells were
incubated for 18 h with LPS (30 ng/ml) and cytokines were analyzed
in cell-supernatants by ELISA. Results are expressed in pg/ml and
represent the arithmetic mean 6 SEM of 4–5 experiments. *, p,0.05 for
M+MSC+ASA vs M+MSC, and for M+LPS+PGE2 vs M+LPS.
doi:10.1371/journal.pone.0009252.g004
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medium (50% V/V) (Sn). After washing, cells were treated with
LPS (30 ng/ml) in the presence of OVA (500 mg/ml) for 18 hs.
Then, M were washed and incubated with CFSE-labelled OT-II
T CD4
+ cells for 72 h. Cells were stained with PE-labeled anti-
CD4 mAb, and the proliferation of the CFSE-labelled T CD4+
cells was analyzed by flow cytometry. Figure 5B shows a
representative experiment (n=5) indicating that supernatants
from MSC markedly suppress the ability of LPS-activated M to
induce the proliferation of OTII T CD4+ cells (% inhibi-
tion=59614, n=5, p,0.05 vs controls).
MSC stimulate phagocytosis of apoptotic thymocytes by
inflammatory macrophages
In the last few years it has become clear that, like dendritic cells
and T cells, macrophages display remarkable plasticity. Upon
activation they can differentiate into different profiles according
the microenvironment stimuli [34–37]. The profile of cytokines
produced by M cultured with MSC support the notion that M
differentiate into a regulatory or alternative profile under the
influence of MSC. Since regulatory macrophages might contribute
to the resolution of inflammatory processes, not only by releasing
anti-inflammatory cytokines but also by promoting the clearance
of apoptotic cells [37,38], we analyzed whether M cultured in the
presence of MSC displayed a higher ability to phagocyte apoptotic
cells. Experiments were performed by incubating M and MSC (M:
MSC ratio=10:1) with apoptotic thymocytes (M: thymocyte
ratio=1:10), for 1 h at 37uC. Phagocytosis was evaluated by
fluorescence microscopy using thymocytes labeled with the green
fluorescent dye CFSE and macrophages stained with PE-labeled
IgG antibodies directed to CD11b. Results in Figure 6A–C show
that MSC stimulated phagocytosis of apoptotic thymocytes by
macrophages. Interestingly, a similar enhancing effect was found
using supernatants collected from MSC grown to confluence
during 24 h (Figure 6D), supporting that stimulation of
phagocytosis of apoptotic cells is mediated by the release of
factor(s) constitutively produced by MSC. On the other hand, the
fact that M cultured with MSC showed no stimulation in their
ability to phagocytize zymosan particles (Figure 6E) strongly
suggests that the increased ability to phagocytize apoptotic cells do
not merely reflect a higher endocytic ability of M cultured with
MSC. Recognition of apoptotic cells by phagocytes involves a
number of receptors able to recognize ‘‘eat-me signals’’ expressed
on the surface of apoptotic cells [39]. Among these receptors
expressed by macrophages the scavenger receptor CD36 and the
glycosylphosphatidylinositol-anchored LPS receptor CD14 appear
to play an important role [39,40]. To analyze whether the ability
of MSC to stimulate phagocytosis of apoptotic thymocytes by
macrophages was related to an increased expression of receptors
able to recognize apoptotic cells we analyzed the expression of
CD36 and CD14 in M cultured overnight with MSC superna-
tants. Results in Figures 6 F and G show that MSC supernatants
did not increase the expression of CD36 and CD14 by
macrophages, but rather, they significantly reduced the expression
of both receptors.
MSC markedly increase the susceptibility of
macrophages to infection with the parasite Trypanosoma
cruzi
Infection with the protozoan flagellate parasite T. cruzi causes
Chagas’disease, a widely distributed infection which represents a
major health problem in many Latin American countries.
Macrophages are one of the most important targets of T. cruzi
infection [41]. A large body of evidence indicates that classically
activated macrophages play an essential role in host defense
against T. cruzi by virtue of their ability to destroy intracellular
Figure 5. MSC inhibit the up-regulation of CD86 and MHC class
II (Ia
b) in M stimulated by LPS and impairs antigen presenta-
tion to T CD4+ cells. (A) M were cultured overnight in the absence or
presence of MSC (M: MSC ratio=10:1). Cells were then washed and
incubated for 18 h with or without LPS (30 ng/ml), and the expression
of CD86, MHC class II (Ia
b), CD40 and MHC class I (H2D
b) in M was
analyzed using FITC-labeled antibodies directed to CD11b and PE-
labeled antibodies directed to CD86, Ia
b, CD40, and H2D
b, in the gate of
CD11b-positive cells. Results are expressed as the mean fluorescence
intensity (MFI) values and represent the arithmetic mean 6 SEM of 4-5
experiments. *, p,0.05 for M+MSC+LPS vs M+LPS. (B) M (1x10
5 cells/
100 ml) were cultured overnight in 96 well-flat bottom plates with
culture medium alone or MSC-conditioned medium (50% V/V). After
washing, cells were treated with LPS (30 ng/ml) in the presence of OVA
(500 mg/ml) for 18 hs. After this period, M were washed and fresh
culture medium was added. Spleen T CD4+ cells from OT-II mice were
purified and labeled with CFSE, as described under Materials and
Methods. Macrophages and CFSE-labeled OT-II T CD4+ cells were
cultured together (M:T cell ratio 1:5) for 72 h. Cells were stained with
PE-labeled anti-CD4 mAb, and the proliferation of the CFSE-labeled T
CD4+ cells was analyzed by flow cytometry. A representative
experiment is shown (n=5). No proliferation was observed when LPS-
stimulated M were cultured without OVA.
doi:10.1371/journal.pone.0009252.g005
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produced by macrophages under the influence of interferon-c and
TNF-a [42,43]. By contrast, regulatory or alternatively activated
macrophages, for example those activated by IL-4, fail to control
the infection being super-infected [44]. Because our results support
the notion that macrophages differentiate into a regulatory-like
profile under the influence of MSC, we examined whether MSC
increased the susceptibility of M to T. cruzi infection. In these
experiments, M cultured overnight alone or in the presence of
MSC were infected by exposure to T. cruzi trypomastigotes (M: T.
cruzi ratio=1:5) for 3 h. Cells were then washed, and cultured for
an additional period of 48 h. Then, cells were fixed, permeabi-
lized, stained and intracellular amastigotes were identified by
fluorescence microscopy. Results in Figure 7A–C show that the
culture of M with MSC resulted in a marked increase (.5-fold) in
the percentage of infected M. Supernatants collected from MSC
grown to confluence during 24 h failed to reproduce this effect
(data not shown). We conclude that MSC turn inflammatory
macrophages into cells highly susceptible to T. cruzi infection.
Previous studies have shown that the resistance of macrophages to
the infection by T. cruzi is strongly dependent on the expression of
toll-like receptors (TLRs) 2 and 9 which recognize T. cruzi derived
molecules such as GPI anchors and DNA CpG motifs, respectively
[45,46]. To analyze whether MSC might increase the susceptibil-
ity of M to T. cruzi infection by inhibiting the expression of TLRs,
M were cultured overnight in the absence or presence of MSC and
the expression of TLR2 was then analyzed by flow cytometry. A
representative experiment is shown in Figure 7D. A marked
reduction in the expression of TLR2 was observed in M cultured
with MSC compared with M cultured alone: % inhibition in the
expression of TLR2=78616 (n=4, p,0.05 vs controls). This
suggests that the increased susceptibility of M cultured with MSC
to the infection by T. cruzi may be related to a decreased
expression of TLRs.
Additional experiments were performed to analyze whether the
ability of MSC to make macrophages more susceptible to T. cruzi
infection might have an impact in vivo. To this aim, we studied the
effect of MSC on the course of T. cruzi infection in a murine
model. Mice were infected by i.p route with 1610
5 bloodstream
trypomastigotes of the lethal pantropic/reticulotropic RA strain of
T. cruzi. Four and eight days post-infection MSC (2.5610
6/500 ml
pyrogen-free PBS) or PBS (controls) were inoculated by intraper-
Figure 6. MSC stimulate the uptake of apoptotic thymocytes by M. M were cultured overnight in the absence or presence of MSC (M: MSC
ratio 10:1). Apoptotic thymocytes labeled with CFSE were then added (M: thymocyte ratio=1:10), and cells were incubated for 1 h at 37uC. The
number of apoptotic thymocytes inside each macrophage was analyzed by fluorescence microscopy using PE-labeled IgG anti-CD11b. At least 200
macrophages were scored in each experiment. (A) Results are expressed as the number of thymocytes internalized per macrophage and represent
the arithmetic mean 6 SEM of five experiments. *, p,0.05 for M+MSC vs M. (B) Representative images of phagocytosis of apoptotic thymocytes by M
cultured alone (B) or in the presence of MSC (C). (D) MSC grown to confluence were cultured alone for 24 h and the cell-supernatants were then
harvested. M were cultured overnight with or without MSC supernatants (50% V/V). Apoptotic thymocytes labeled with CFSE were then added (M:
thymocyte ratio=1:10), and cells were incubated for 1 h at 37uC. The number of apoptotic thymocytes inside each macrophage was analyzed as
described above. Results represent the arithmetic mean 6 SEM of four experiments. *, p,0.05 for M+Sn vs M. (E) M were cultured overnight in the
absence or presence of MSC (M: MSC ratio 10:1). FITC-labeled zymosan particles (250 m/ml) were then added and phagocytosis was evaluated after 1
h of incubation at 37uC, using PE-labeled IgG anti-CD11b and flow cytometry, in the gate of CD11b-positive cells. Grey histogram represents the
fluorescence of M cultured without zymosan particles. It was similar for M cultured in the absence or presence of MSC. A representative experiment
(n=4) is shown. (F and G) MSC grown to confluence were cultured alone for 24 h and the cell-supernatants were then harvested. M were cultured
overnight with or without MSC supernatants (50% V/V). Cells were washed and the expression of CD36 and CD14 was analyzed by flow cytometry.
Results are expressed as the mean fluorescence intensity (MFI) values and represent the arithmetic mean 6 SEM of 4 experiments. *, p,0.05 for M+Sn
vs M.
doi:10.1371/journal.pone.0009252.g006
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17 post-infection, while mouse deaths were recorded on a daily
basis. The results obtained are showed in Figures 7E and F.
They indicated that administration of MSC modified neither
parasitemia nor the mortality rate of infected mice.
MSC promote the recruitment of macrophages and their
differentiation into a regulatory-like profile in vivo
The lack of effect of MSC on the course of T. cruzi infection
prompted us to investigate their ability to modulate the profile of
macrophages in another experimental model in which MSC were
close together with macrophages at the inflammatory foci. To this
aim we used a non-infectious model of inflammation induced by
s.c. implantation of glass cylinders [25]. These cylinders induce a
strong inflammatory response that leads to both, macrophage
infiltration and the rapid close of both ends of the cylinders by
fibrotic tissue [25, and Isturiz M, personal communication]. One
cylinder was implanted in each mice, and 2 and 7 days later 2610
5
MSC in 50 ml of PBS or PBS alone (controls) were inoculated
inside the cylinders. After 15 days, the liquid content inside the
cylinders were harvested and the levels of TNF-a, IL-12p70, IL-
12p40 and IL-10 were determined by ELISA. At this time,
cylinders were removed from the mice, washed and adherent cells
(.90% macrophages) were detached with a cell scraper at 4uC,
counted, and characterized by flow cytometry. Figure 8A show
that MSC enhanced the infiltration of the cylinders by
macrophages. In fact, MSC-treated cylinders contained a number
of macrophages at least 3-fold higher compared with untreated
cylinders. Moreover, these macrophages expressed lower levels of
the class II molecule Ia
b and CD86 compared with macrophages
from untreated cylinders (Figures 8B and C). The analysis of
cytokines in the liquid harvested from the inside of the cylinders
(Figure 8D) revealed that MSC-treated cylinders contained lower
levels of IL-12 p70 and higher levels of IL-10 and IL-12p40,
compared with untreated cylinders. Low levels of TNF-a were
detected in both untreated and MSC-treated cylinders.
Discussion
Mesenchymal stromal cells have emerged as a promising
therapeutic tool in regenerative medicine. Although little is known
about the in vivo behavior of MSC, they have been introduced in
the clinic with encouraging preliminary results [2,5,47]. The
mechanisms underlying the therapeutic properties of MSC are not
well defined. They have been classically related to the stem-cell-
like properties of MSC. Recent findings, however, suggest that the
therapeutic properties of MSC in a variety of settings are due to
their anti-inflammatory and immunomodulatory abilities
[2,4,5,47]. In fact, the immunomodulatory effects of MSCs have
Figure 7. MSC turn M into cells highly susceptible to T. cruzi infection. M were cultured overnight in the absence or presence of MSC (M: MSC
ratio 10:1). T. cruzi trypomastigotes (M: T. cruzi ratio=1:5) were then added and incubated for 3 h. Cells were then washed, and cultured for 45 h.
Finally, cells were fixed, permeabilized, stained and the presence of intracellular amastigotes was analyzed by fluorescence microscopy as described
under Materials and Methods. (A and B) Representative images of intracellular amastigotes in M cultured overnight in the absence (A) or presence (B)
of MSC. (C) Results are expressed as the percentage of infected macrophages and represent the arithmetic mean 6 SEM of five experiments. *,
p,0.05 for M+MSC vs M. (D) M were cultured overnight in the absence or presence of MSC (M: MSC ratio 10:1). Cells were then washed and the
expression of TLR2 in M was analyzed using PE-labeled antibodies directed to TLR2, in the gate of CD11b(FITC)-positive cells. Grey histogram
represents the isotype control. A representative experiment (n=4) is shown. (E and F) Two-months old C57Bl/6 female mice were infected by
intraperitoneal (IP) route with 1610
5 bloodstream trypomastigotes of the lethal pantropic/reticulotropic RA strain of T. cruzi. MSC (2.5610
6/500 ml
pyrogen-free PBS) or PBS (controls) were inoculated by intraperitoneal route at days 4 and 10 post-infection. (F) Parasitemia was measured at days 8,
14, and 17 post-infection and the results are expressed as the number of T cruzi/ml blood (n=10 for each experimental group). (E) Mouse deaths
were recorded on a daily basis. Results are expressed as survival percent (n=10 for each experimental group).
doi:10.1371/journal.pone.0009252.g007
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animal models related to either alloreactive immunity, autoim-
munity or anti-tumor immunity [2,4,5,47].
Many studies have been performed to characterize the
immunomodulatory effects mediated by MSC. These studies have
mainly focused on the action exerted on T and B lymphocytes,
dendritic cells, and NK cells [4–18]. Little attention has been paid
to the analysis of macrophage function. Two recent studies have
analyzed this subject. Ne ´meth, K et al. [48] showed that
administration of MSC to mice before or shortly after inducing
sepsis by cecal ligation and puncture reduced mortality and
improved organ function. The beneficial effect of MSC was
eliminated by macrophage depletion or by blocking antibodies
directed to the cytokine IL-10 or the IL-10 receptor. This supports
that the therapeutic action mediated by MSC is induced through
the stimulation of IL-10 production by macrophages. The authors
also showed, in vitro, that MSC increased the production of IL-10
by LPS-stimulated macrophages and demonstrated that this effect
is mediated by PGE2 released by MSC. Moreover, Gupta et al.
[49] showed that intrapulmonary delivery of bone marrow-derived
mesenchymal stromal cells improves survival and attenuates
endotoxin-induced acute lung injury in mice. The analysis of
cytokines in bronchoalveolar lavage and plasma of endotoxin-
challenged mice revealed in MSC-treated mice, lower concentra-
tions of TNF-a and MIP-2 and higher concentrations of IL-10
compared with untreated mice. No differences were found in the
levels of PGE2. Because alveolar macrophages are the prominent
source of cytokines in this model of acute inflammation the authors
also analyzed in vitro whether MSC were able to modulate the
production of cytokines by alveolar macrophages stimulated by
LPS. They found that MSC exert a low but significant inhibitory
effect on the production of TNF-a without affecting the
production of MIP-2, while the levels of IL-10 were undetectable.
Together, the studies carried out by Ne ´meth [48] and Gupta [49]
in two different models of acute inflammation support the notion
that MSC are able to inhibit the inflammatory response mediated
by macrophages through PGE2-dependent or independent
mechanisms.
Our observations showing that MSC suppress the production of
TNF-a by inflammatory-peritoneal macrophages stimulated by
LPS are consistent with the results reported by Ne ´meth [48] and
Gupta [49], and also by Yang et al. [50]. We also found that other
inflammatory cytokines such as IL-6, IL-12p70 and IFN-c are
suppressed under the influence of MSC while the production of
IL-10 was significantly enhanced. Of note, the ability of MSC to
inhibit the production of the cytokines IL-12p70 and IFN-c
Figure 8. MSC stimulate ‘‘in vivo’’ the recruitment of macrophages and direct their differentiation into a regulatory-like profile. A
Glass cylinder of 2 cm long, 8 mm wide and around 200 ml internal volume was implanted s.c. into 8-to 12-week-old C57BL/6 mice. Two and 7 days
after the cylinders were implanted in the mice, 2610
5 MSC in 50 ml of pyrogen free-PBS or PBS alone (controls) were inoculated inside the cylinders,
using a 22 g needle. After 15 days the liquid content of the cylinders was aspirated and the levels of the cytokines TNF-a, IL-12p70, IL-12p40 and IL-10
were determined by ELISA (D). Cylinders were removed, washed with saline and placed in cold PBS (4uC) for 30 min. Adherent cells (.90%
macrophages) were removed from the interior of each cylinder to obtain a single cell suspension. The number of the macrophages recruited in each
cylinder was measured (A), and their expression of Ia
b and CD86 was analyzed by flow cytometry (B-C). Results represent the arithmetic mean 6 SEM
(n=12 for each experimental group). *, p,0.05 for Controls (CT) vs MSC.
doi:10.1371/journal.pone.0009252.g008
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by inhibiting the production of pro-inflammatory cytokines during
the early step of the inflammatory process, but also by suppressing
the induction of Th1 responses which are mainly dependent on
IL-12p70 and IFN-c. We also observed that MSC markedly
increase the production of IL-12p40 by LPS-activated M. The p40
chain is the common subunit of IL-12p70 and IL-23, but it also
secreted as a p80 homodimer [51]. We did not detect any
production of IL-23 by M. This observation together with our
results indicating that MSC profoundly inhibits the production of
IL12p70 suggests that a large proportion of the p40 produced by
LPS-activated M under the influence of MSC might be secreted as
a p80 homodimer. Interestingly, it has been suggested that the p80
homodimer binds to the IL-12 receptor and acts as a potent IL-
12p70 antagonist [52,53].
Our results suggest that MSC switch the macrophages to an
anti-inflammatory profile not only by suppressing the production
of inflammatory cytokines enhancing the production of IL-10, but
also by stimulating the phagocytosis of apoptotic cells, a novel
mechanism through which MSC might contribute to ameliorate
tissue injury. Interestingly, all these effects were induced by either
MSC or supernatants collected from unstimulated MSC cultured
alone, indicating that the modulatory action exerted by MSC on
macrophage function is largely mediated by factors constitutively
produced by MSC. This contrasted with previous studies directed
to characterize certain immunomodulatory effects mediated by
MSC on T and B lymphocytes, since they appeared to require
some degree of MSC activation [4,5,14].
The clearance of apoptotic cells plays a critical role in the
resolution of inflammatory processes [54]. In fact, inflammation
usually involves the local recruitment of large number of
leukocytes which undergo apoptosis at the inflammatory foci. If
apoptotic cells are not efficiently removed they release intracellular
constituents able to further increase the course of inflammation,
among them, ATP, K
+ ions, uric acid, high-mobility group box 1
protein (HMGB1) and several members of the S100 calcium-
binding protein family [55]. The mechanisms through which MSC
increase phagocytosis of apoptotic thymocytes by macrophages
remain to be determined. MSC were completely unable to
increase the uptake of zymosan particles by macrophages,
supporting that the increased ability of macrophages to phagocy-
tize apoptotic cells is not due to an improved efficiency of their
phagocytic machinery. Moreover, two important receptors
involved in the recognition of apoptotic cells, CD36 and CD14,
were down-regulated in M cultured under the influence of MSC.
It should be noted, however, that the uptake of apoptotic cells by
professional phagocytes depends, besides CD36 and CD14, on a
complex system of receptors [39,40], some of which might be up-
regulated in macrophages under the influence of MSC.
Of note, we found that MSC induce a marked increase in the
susceptibility of macrophages to infection with the protozoan
flagellate parasite T. cruzi the etiologic agent of Chagas’disease
[41]. The mechanisms responsible for the inherent relative
resistance of macrophages to infection by T. cruzi appear to be
linked to the production of the inflammatory cytokines TNF-a, IL-
12p70, and IFN-c which drive nitric oxide production [41–44].
Our results showing that MSC down-regulated the production of
all of these cytokines in LPS-stimulated macrophages suggest that
a diminished ability to produce inflammatory cytokines might be
the reason for the increased susceptibility to infection. Interest-
ingly, and contrasting with the suppression of inflammatory
cytokines found in LPS-stimulated macrophages, we observed that
supernatants from MSC failed to increase the susceptibility of
macrophages to T. cruzi-infection (unpublished results) suggesting
that cell-to-cell contact-dependent mechanisms are involved.
Previous studies have shown that when macrophages and T. cruzi
are co-incubated in vitro, macrophage resistance to infection
requires the expression of TLRs 2 and 9 which recognize T. cruzi-
derived pathogen-associated molecular patterns (PAMPs) leading
to the activation of potent microbicidal mechanisms [45,46]. We
did not study the expression of TLR9 but found that MSC
induced a marked decrease in the expression of TLR2 which
might explain, at least in part, the enhanced macrophage
susceptibility to T. cruzi infection. On the other hand, in the
experiments directed to evaluate whether the adoptive transfer of
MSC to T. cruzi infected mice resulted in a more aggressive course
of infection, we failed to detect any effect. Not only parasitemia
levels but also the rates of death of infected mice were similar in
untreated and MSC-treated mice. Since MSC appear to enhance
the susceptibility of macrophages to T. cruzi infection by cell-to cell
contact-dependent mechanisms, this results might reflect the
inability of MSC to reach the major sites of parasite multiplication
such as the spleen and the liver.
Guided by this presumption, we then analyzed in vivo the
immunomodulatory activity of MSC in another experimental
model in which MSC were close together with macrophages
during the course of an inflammatory response. Subcutaneous
implantation of glass cylinders induces a strong inflammatory
response leading to both, macrophage infiltration in the interior of
the cylinders and the rapid occlusion of both ends of the cylinders
by fibrotic tissue [25], thus favoring the retention of transferred
MSC inside the cylinders. In this model, we found that MSC
enhanced the infiltration of the glass cylinders by macrophages.
Consistent with our in vitro observations, these macrophages
showed low levels of the class II molecule Ia
b and CD86.
Moreover, the analysis of the liquid content of the cylinders
revealed that MSC-treated cylinders contained lower levels of IL-
12 p70 and higher levels of IL-10 and IL-12p40, compared with
untreated cylinders. Low levels of TNF-a were found in both
untreated and MSC-treated cylinders. Together, these results
support the notion that during the course of an inflammatory
response MSC might favor the resolution of inflammation via the
recruitment and differentiation of macrophages into a regulatory-
like profile.
Our results show that MSC impose dramatic changes in the
function of macrophages inhibiting the production of anti-
inflammtory cytokines, promoting their ability to phagocytize
apoptotic cells and enhancing their susceptibility to T. cruzi
infection. Interestingly, each of the changes appears to involve, at
least partially, different mechanisms. Experiments performed with
ASA and PGE2 support a relevant role for PGE2 in the ability of
MSC to modulate the cytokine profile of activated macrophages.
By contrast, PGE2 does not appear to be involved in the
stimulation of the phagocytosis of apoptotic cells by macrophages.
In fact, previous studies have already shown that PGE2 did not
modify [56] or significantly suppress [57], the uptake of apoptotic
cells by macrophages. Consistent with these observations, we
found that PGE2 did not increase the uptake of apoptotic
thymocytes by macrophages (Maggini J, unpublished observation).
Finally, the enhanced susceptibility of macrophages to T cruzi
infection induced by MSC appeared to be mainly dependent on
mechanisms that require the physical interaction between MSC
and macrophages. Thus, our results suggest that MSC display
different mechanisms to modulate the functional profile of
macrophages.
Not only dendritic cells and T cells, but also macrophages,
display a remarkable plasticity and can dramatically change their
physiology in response to environmental stimuli. Mosser and
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macrophages based on three different homeostatic activities; host
defense (classically-activated macrophages), wound healing
(wound-healing macrophages) and immune regulation (regulatory
macrophages). Our results support the notion that under the
influence of MSC, classically activated macrophages turn into
wound-healing or regulatory macrophages, suggesting a novel
mechanism through which MSC might modulate the course of the
immune response.
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